One Global Service Provider Approves ₹39.54 Crore Diagnostics Acquisition

Board approved acquisition of 51% each in MLDPL and MLPL for Rs 36.0 Cr and Rs 3.6 Cr, via 7.15 lakh preferential shares at Rs 553. First equity issuance since listing; expands the healthcare strategy into IVD diagnostics, medical equipment, manufacturing and technical services. Share swap avoids cash outlay but dilutes holders; target profitability, valuation detail and completion remain undisclosed, subject to approvals within six months.